Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:CONNASDAQ:GHNASDAQ:OPCHNASDAQ:RDNT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCONConcentra Group Holdings Parent$21.18+0.9%$21.45$18.89▼$24.81$2.69BN/A749,034 shs696,446 shsGHGuardant Health$49.99+3.0%$44.62$20.14▼$52.92$6.01B1.372.14 million shs1.59 million shsOPCHOption Care Health$32.26+3.9%$32.06$21.39▼$35.53$5.08B0.741.88 million shs1.29 million shsRDNTRadNet$55.78+1.7%$55.52$45.00▼$93.65$4.12B1.43682,867 shs604,374 shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCONConcentra Group Holdings Parent+1.08%+0.36%+0.19%-1.51%+2,117,699,900.00%GHGuardant Health+2.97%+0.93%+31.55%+9.05%+71.85%OPCHOption Care Health+3.90%+1.32%+2.71%-7.91%+12.56%RDNTRadNet+1.66%-1.38%-1.47%+9.98%-3.96%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCONConcentra Group Holdings Parent3.0717 of 5 stars3.50.02.50.02.60.01.3GHGuardant Health3.6847 of 5 stars2.53.00.04.31.52.50.6OPCHOption Care Health3.7575 of 5 stars2.43.00.04.23.11.70.6RDNTRadNet3.407 of 5 stars2.82.00.04.61.32.50.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCONConcentra Group Holdings Parent 3.00Buy$28.5034.58% UpsideGHGuardant Health 3.00Buy$53.767.55% UpsideOPCHOption Care Health 2.88Moderate Buy$35.5010.04% UpsideRDNTRadNet 3.50Strong Buy$69.6024.78% UpsideCurrent Analyst Ratings BreakdownLatest CON, GH, OPCH, and RDNT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/18/2025OPCHOption Care HealthJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$36.006/13/2025GHGuardant HealthMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$60.00 ➝ $65.006/13/2025RDNTRadNetB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy ➝ Buy$69.006/12/2025RDNTRadNetB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeBuy ➝ Strong-Buy5/6/2025GHGuardant HealthPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$50.00 ➝ $60.005/5/2025GHGuardant HealthScotiabankSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform5/5/2025GHGuardant HealthScotiabankSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetSector Outperform ➝ Sector Outperform$52.00 ➝ $57.005/1/2025GHGuardant HealthCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$60.00 ➝ $65.005/1/2025GHGuardant HealthTD SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$56.00 ➝ $60.005/1/2025GHGuardant HealthBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$55.00 ➝ $60.005/1/2025GHGuardant HealthStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$53.00 ➝ $60.00(Data available from 6/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCONConcentra Group Holdings Parent$1.90B1.43$1.86 per share11.36$2.20 per share9.63GHGuardant Health$739.02M8.38N/AN/A($1.13) per share-44.24OPCHOption Care Health$5.00B1.06$1.71 per share18.88$8.25 per share3.91RDNTRadNet$1.83B2.29$3.54 per share15.75$15.31 per share3.64Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCONConcentra Group Holdings Parent$166.54M$1.3415.8016.291.988.09%29.94%6.31%7/28/2025 (Estimated)GHGuardant Health-$436.37M-$3.39N/AN/AN/A-53.82%-1,200.44%-26.77%8/6/2025 (Estimated)OPCHOption Care Health$211.82M$1.2426.0225.601.884.12%16.90%7.00%7/30/2025 (Estimated)RDNTRadNet$2.79M-$0.43N/A105.25N/A-1.73%1.41%0.48%8/6/2025 (Estimated)Latest CON, GH, OPCH, and RDNT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/7/2025Q1 2025CONConcentra Group Holdings Parent$0.31$0.32+$0.01$0.30$496.06 million$500.80 million4/30/2025Q1 2025GHGuardant Health-$0.57-$0.49+$0.08-$0.77$189.91 million$203.47 million4/29/2025Q1 2025OPCHOption Care Health$0.36$0.40+$0.04$0.28$1.26 billion$1.33 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCONConcentra Group Holdings Parent$0.251.18%N/A18.66%N/AGHGuardant HealthN/AN/AN/AN/AN/AOPCHOption Care HealthN/AN/AN/AN/AN/ARDNTRadNetN/AN/AN/AN/AN/ALatest CON, GH, OPCH, and RDNT DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/8/2025CONConcentra Group Holdings Parentquarterly$0.06251.2%5/20/20255/20/20255/29/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCONConcentra Group Holdings Parent5.181.101.10GHGuardant HealthN/A4.113.76OPCHOption Care Health0.821.541.02RDNTRadNet0.872.012.01Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCONConcentra Group Holdings ParentN/AGHGuardant Health92.60%OPCHOption Care Health98.05%RDNTRadNet77.90%Insider OwnershipCompanyInsider OwnershipCONConcentra Group Holdings Parent6.60%GHGuardant Health6.10%OPCHOption Care Health0.64%RDNTRadNet5.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCONConcentra Group Holdings Parent11,250128.17 million119.71 millionN/AGHGuardant Health2,021123.89 million116.33 millionNot OptionableOPCHOption Care Health8,088163.75 million162.70 millionOptionableRDNTRadNet11,02175.03 million70.83 millionOptionableCON, GH, OPCH, and RDNT HeadlinesRecent News About These CompaniesEarly Detection Revolution: RadNet implements AI into low-dose CTJune 23 at 8:40 PM | ladowntownnews.comSG Americas Securities LLC Raises Position in RadNet, Inc. (NASDAQ:RDNT)June 22 at 3:12 AM | marketbeat.comRadNet (NASDAQ:RDNT) Upgraded by Wall Street Zen to "Hold" RatingJune 22 at 2:25 AM | americanbankingnews.comRadNet (NASDAQ:RDNT) Upgraded at Wall Street ZenJune 21, 2025 | marketbeat.comRadNet (NASDAQ:RDNT) Might Be Having Difficulty Using Its Capital EffectivelyJune 20, 2025 | finance.yahoo.comRadNet, Inc. (NASDAQ:RDNT) Receives $69.60 Consensus Target Price from AnalystsJune 18, 2025 | americanbankingnews.comB. Riley Initiates Coverage on RadNet (NASDAQ:RDNT)June 16, 2025 | americanbankingnews.comRadNet, Inc. (NASDAQ:RDNT) Given Consensus Rating of "Strong Buy" by AnalystsJune 15, 2025 | marketbeat.comRadNet (NASDAQ:RDNT) Upgraded by B. Riley to Strong-Buy RatingJune 14, 2025 | marketbeat.comRadNet (NASDAQ:RDNT) Coverage Initiated by Analysts at B. RileyJune 13, 2025 | marketbeat.com1 of Wall Street’s Favorite Stock with Promising Prospects and 2 to Be Wary OfJune 12, 2025 | msn.comRadNet, Inc. Secures $100 Million Incremental Term Loan to Support Strategic Growth InitiativesJune 11, 2025 | quiverquant.comRadNet Secures $100 Million Incremental Term Loan to Fund Acquisitions and Corporate InitiativesJune 11, 2025 | globenewswire.comGAMMA Investing LLC Buys 80,396 Shares of RadNet, Inc. (NASDAQ:RDNT)June 11, 2025 | marketbeat.comRadNet, Inc. (NASDAQ:RDNT) is Harbor Capital Advisors Inc.'s 4th Largest PositionJune 10, 2025 | marketbeat.comE. Ohman J or Asset Management AB Buys 5,300 Shares of RadNet, Inc. (NASDAQ:RDNT)June 7, 2025 | marketbeat.comRDNT Q1 Earnings Call: Severe Weather Disruptions and Ongoing Shift to Advanced Imaging Highlight ResultsJune 6, 2025 | msn.comRadNet Acquires See-Mode Technologies to Enhance AI Ultrasound ImagingJune 5, 2025 | insidermonkey.comRadNet Acquires Ultrasound Firm See-Mode TechnologiesJune 4, 2025 | marketwatch.comRadNet, Inc. Acquires See-Mode Technologies for Innovation in AI-Powered Ultrasound DiagnosticsJune 4, 2025 | globenewswire.comWellington Management Group LLP Trims Stake in RadNet, Inc. (NASDAQ:RDNT)June 1, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesBigBear.ai Poised to Benefit as Palantir Dominates AI DefenseBy Gabriel Osorio-Mazilli | June 23, 2025View BigBear.ai Poised to Benefit as Palantir Dominates AI DefenseIntel’s Turnaround May Be the Best Bet No One’s WatchingBy Jeffrey Neal Johnson | May 30, 2025View Intel’s Turnaround May Be the Best Bet No One’s WatchingBullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsBy Thomas Hughes | May 27, 2025View Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsNavitas Soars on NVIDIA Deal: Breaking Down Its Tech and OutlookBy Leo Miller | May 27, 2025View Navitas Soars on NVIDIA Deal: Breaking Down Its Tech and OutlookAmong the Market’s Most Shorted: 2 Firms With +40% Short InterestBy Leo Miller | June 3, 2025View Among the Market’s Most Shorted: 2 Firms With +40% Short InterestCON, GH, OPCH, and RDNT Company DescriptionsConcentra Group Holdings Parent NYSE:CON$21.18 +0.20 (+0.94%) Closing price 06/24/2025 03:59 PM EasternExtended Trading$21.18 +0.00 (+0.01%) As of 06/24/2025 06:13 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Concentra Group Holdings Parent, Inc. provides occupational health services in the United States. The company offers occupational and consumer health services, including workers' compensation injury care, urgent care, clinical testing, preventative care, and employer services, as well as wellness programs through occupational health centers and onsite clinics. It also provides Concentra Telemed, a telemedicine solution for the treatment of work-related injuries and illnesses, and employer services; pharmacy solution under the Concentra Pharmacy name; and Concentra Medical Compliance Administration, a third-party administrator that helps to manage abuse testing programs for employers with regulated or non-regulated workforces. The company was founded in 1979 and is based in Mechanicsburg, Pennsylvania. Concentra Group Holdings Parent, Inc. is a subsidiary of Select Medical Corporation.Guardant Health NASDAQ:GH$49.99 +1.44 (+2.97%) Closing price 06/24/2025 04:00 PM EasternExtended Trading$50.24 +0.25 (+0.51%) As of 06/24/2025 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.Option Care Health NASDAQ:OPCH$32.26 +1.21 (+3.90%) Closing price 06/24/2025 04:00 PM EasternExtended Trading$32.03 -0.23 (-0.70%) As of 06/24/2025 06:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.RadNet NASDAQ:RDNT$55.78 +0.91 (+1.66%) Closing price 06/24/2025 04:00 PM EasternExtended Trading$55.80 +0.02 (+0.03%) As of 06/24/2025 07:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as AI solutions for prostate cancer screening. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 3 Hot Trades for Insiders, But Are They Good Buys for Investors? Why Qualcomm’s Latest Price Target Can't Be Ignored Texas Instruments Stock: Congress Likes It, Should You Too? Geospace Stock Skyrockets After Major Petrobras Contract Analyst Sees Meta Hitting $800: What May Lead Shares to New Highs CrowdStrike Eyes Breakout as Cyber Threats Boost Demand Reddit Stock Ignites: Surge in Call Options Signals Big Bet Microsoft Stock Holds Steady as AI Drives Workforce Shift Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
